These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 19205620)
21. [Immunophenotypic features of acute myeloid leukemia with AML-1/ETO fusion gene]. Zhang JJ; DU X; Huang ZX; Su JH; Zhou MH Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):378-81. PubMed ID: 17493351 [TBL] [Abstract][Full Text] [Related]
22. Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Creutzig U; Harbott J; Sperling C; Ritter J; Zimmermann M; Löffler H; Riehm H; Schellong G; Ludwig WD Blood; 1995 Oct; 86(8):3097-108. PubMed ID: 7579404 [TBL] [Abstract][Full Text] [Related]
23. [Immunophenotypic analysis of acute myeloid leukemia with t(8;21)]. Fan L; Wu YJ; Zhang JF; Qiu HR; Qiao C; Wang R; Yang H; Xu W; Li JY Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1410-3. PubMed ID: 21176340 [TBL] [Abstract][Full Text] [Related]
24. The value of CD64 expression in distinguishing acute myeloid leukemia with monocytic differentiation from other subtypes of acute myeloid leukemia: a flow cytometric analysis of 64 cases. Dunphy CH; Tang W Arch Pathol Lab Med; 2007 May; 131(5):748-54. PubMed ID: 17488160 [TBL] [Abstract][Full Text] [Related]
25. [The immunophenotypic analysis of CD7+ and (or) CD56+ acute myeloid leukemic stem cells and its applications in minimal residual disease detection]. Cao H; Wang YZ; Wu HH; Chang Y; Hao L; Chen SS; Huang XJ; Lu DP; Liu YR Zhonghua Xue Ye Xue Za Zhi; 2008 Jan; 29(1):23-8. PubMed ID: 18512311 [TBL] [Abstract][Full Text] [Related]
26. [Relationship between immunological characteristics and prognosis in children with acute myeloid leukemia]. Gu LJ; Tie LJ; Jiang LM; Chen J; Pan C; Dong L; Chen J; Xue HL; Tang JY; Wang YP; Ye H Zhongguo Dang Dai Er Ke Za Zhi; 2009 Apr; 11(4):241-5. PubMed ID: 19374802 [TBL] [Abstract][Full Text] [Related]
27. [Immunophenotyping of 106 adult patients with acute leukemia by flow cytometry]. Xu B; Hu C; Miao XD; Wu YH; Yi ZS; Yang Y; Meng FY; Feng R; Liu QF; Liu XL; Zheng WY Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1043-6. PubMed ID: 14559689 [TBL] [Abstract][Full Text] [Related]
28. Characterization of aberrant phenotypes in acute myeloblastic leukemia. Macedo A; Orfão A; Vidriales MB; López-Berges MC; Valverde B; González M; Caballero MD; Ramos F; Martínez M; Fernández-Calvo J Ann Hematol; 1995 Apr; 70(4):189-94. PubMed ID: 7748963 [TBL] [Abstract][Full Text] [Related]
29. Transient myeloproliferative disorder and acute myeloid leukemia in Down syndrome. An immunophenotypic analysis. Karandikar NJ; Aquino DB; McKenna RW; Kroft SH Am J Clin Pathol; 2001 Aug; 116(2):204-10. PubMed ID: 11488066 [TBL] [Abstract][Full Text] [Related]
30. Aberrant lymphoid antigen expression in acute myeloid leukemia in Saudi Arabia. El-Sissy AH; El-Mashari MA; Bassuni WY; El-Swaayed AF J Egypt Natl Canc Inst; 2006 Sep; 18(3):244-9. PubMed ID: 17671534 [TBL] [Abstract][Full Text] [Related]
31. Clinical and hematological correlates of aberrant immunophenotypic profiles in adult and pediatric acute myeloid leukemia at presentation. Sharma M; Varma N; Singh Sachdeva MU; Bose P; Varma S J Cancer Res Ther; 2020; 16(1):105-109. PubMed ID: 32362618 [TBL] [Abstract][Full Text] [Related]
32. Acute myeloid leukemia: correlation between purine metabolism enzyme activities and membrane immunophenotype. Mesárosová A; Hrivnáková A; Babusíková O Neoplasma; 1993; 40(6):341-5. PubMed ID: 8289964 [TBL] [Abstract][Full Text] [Related]
33. [Analysis of immunophenotypes and expressions of non-myeloid antigens in acute myeloid leukemia]. Wang W; Xu Y Nan Fang Yi Ke Da Xue Xue Bao; 2020 Nov; 40(11):1639-1644. PubMed ID: 33243747 [TBL] [Abstract][Full Text] [Related]
34. The presence of lymphoid-associated antigens in adult acute myeloid leukemia is devoid of prognostic relevance. Lauria F; Raspadori D; Ventura MA; Rondelli D; Testoni N; Tosi P; Michieli M; Damiani D; Motta MR; Tura S Stem Cells; 1995 Jul; 13(4):428-34. PubMed ID: 7549902 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience. Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638 [TBL] [Abstract][Full Text] [Related]
36. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry. Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125 [TBL] [Abstract][Full Text] [Related]
37. [Clinical analysis of HLA-DR-negative non-M3 AML]. Mori H; Sakai H; Sanada M; Shimamoto K; Sasaki S; Azuma R; Higuchi T; Harada H; Niikura H; Omine M; Fujita K; Takahashi N Rinsho Ketsueki; 2007 Jul; 48(7):547-53. PubMed ID: 17695303 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of immunophenotyping in acute myeloid leukemia. Australian Leukaemia Study Group. Bradstock K; Matthews J; Benson E; Page F; Bishop J Blood; 1994 Aug; 84(4):1220-5. PubMed ID: 8049437 [TBL] [Abstract][Full Text] [Related]
39. Immunophenotyping of acute myeloid leukaemia: relevance of analysing different lineage-associated markers. Lo Coco F; Pasqualetti D; Lopez M; Panzini E; Gentile A; Latagliata R; Monarca B; De Rossi G Blut; 1989 May; 58(5):235-40. PubMed ID: 2720173 [TBL] [Abstract][Full Text] [Related]
40. Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). Medeiros BC; Kohrt HE; Arber DA; Bangs CD; Cherry AM; Majeti R; Kogel KE; Azar CA; Patel S; Alizadeh AA Leuk Res; 2010 May; 34(5):594-7. PubMed ID: 19781775 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]